These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39321228)

  • 21. Can positron emission tomography be more than a diagnostic tool? A survey on clinical practice among radiation oncologists in India.
    Thomas HM; Balukrishna S; Devakumar D; Muthuswamy P; Samuel EJ
    Indian J Cancer; 2014; 51(2):145-9. PubMed ID: 25104197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer.
    Alongi F; De Bari B; Franco P; Ciammella P; Chekrine T; Livi L; Jereczek-Fossa BA; Filippi AR;
    Radiol Med; 2013 Jun; 118(4):660-78. PubMed ID: 23358818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert survey on management of prostate cancer in India: Real-world insights into practice patterns.
    Bakshi G; Tongaonkar H; Addla S; Menon S; Pradhan A; Kumar A; Bapat A; Gore A; Joshi A; Raja A; Bradoo A; Ramesh A; Kumar A; Agrawal A; Ambekar A; Joshi A; Singh A; Singh BP; Dabkara D; Khadakban D; Gautam G; Prakash G; Pahwa HS; Goel HK; Kulkarni J; Mishra JJ; Patel K; Pal M; Chibber PJ; Tiwari P; Naik R; Raghunath SK; Krishnatry R; Shimpi R; Sharma R; Taran R; Trivedi S; Nabar S; Surekha S; Kumar S; Sawaimoon SK; Raina S; Narasimha S; Advani S; Ghouse SM; Muddu VK; Maniar V; Venkat V; Murthy V
    Indian J Cancer; 2022 Mar; 59(Supplement):S19-S45. PubMed ID: 35343189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group.
    Belkacemi Y; Latorzeff I; Hasbini A; Coraggio G; Pasquier D; Toledano A; Hennequin C; Bossi A; Chapet O; Crehange G; Guerif S; Duberge T; Allouache N; Clavere P; Gross E; Supiot S; Azria D; Bolla M; Sargos P
    Cancer Radiother; 2020 Dec; 24(8):892-897. PubMed ID: 33144063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Insights on Genetic Testing in Primary Prostate Cancer.
    Kafka M; Surcel C; Heidegger I
    Mol Diagn Ther; 2021 Jul; 25(4):425-438. PubMed ID: 34118026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group.
    Lucchini R; Francolini G; Matrone F; Timon G; Franzese C; Marvaso G; Borghetti P; Nicosia L; Trodella LE; Vinciguerra A; Jereczek-Fossa BA; Arcangeli S
    Med Oncol; 2021 Nov; 39(1):3. PubMed ID: 34739613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
    Leongamornlert DA; Saunders EJ; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Benafif S; Brook MN; Donovan JL; Hamdy FC; Neal DE; Muir K; Govindasami K; Conti DV; Kote-Jarai Z; Eeles RA
    Eur Urol; 2019 Sep; 76(3):329-337. PubMed ID: 30777372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations of transesophageal echocardiography practices in India: A survey by Indian College of Cardiac Anaesthesia.
    Borde DP; George A; Joshi S; Nair S; Koshy T; Gandhe U; Chakravarthy M
    Ann Card Anaesth; 2016; 19(4):646-652. PubMed ID: 27716695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Testing in Prostate Cancer.
    Sokolova AO; Cheng HH
    Curr Oncol Rep; 2020 Jan; 22(1):5. PubMed ID: 31974718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of neonatal diabetes mellitus: A survey of physicians' perceptions and practices in ASPED countries.
    Habeb AM; Deeb A; Elbarbary N; Beshyah SA
    Diabetes Res Clin Pract; 2020 Jan; 159():107975. PubMed ID: 31830516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LungCARD - Report on worldwide research and clinical practices related to lung cancer.
    Jankovic R; J Goncalves H; Cavic M; Clemente C; Lind M; Murillo Carrasco A; Nadifi S; Khyatti M; Adebambo T; Egamberdiev D
    J BUON; 2019; 24(1):11-19. PubMed ID: 30941946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.
    Gómez Caamaño A; Zapatero A; López Torrecilla J; Maldonado X
    Clin Transl Oncol; 2016 Sep; 18(9):884-92. PubMed ID: 26621508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
    Szymaniak BM; Facchini LA; Giri VN; Antonarakis ES; Beer TM; Carlo MI; Danila DC; Dhawan M; George D; Graff JN; Gupta S; Heath E; Higano CS; Liu G; Molina AM; Paller CJ; Patnaik A; Petrylak DP; Reichert Z; Rettig MB; Ryan CJ; Taplin ME; Vinson J; Whang YE; Morgans AK; Cheng HH; McKay RR
    JCO Oncol Pract; 2020 Dec; 16(12):811-819. PubMed ID: 32986533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of genomic testing in advanced non-small cell lung cancer among oncologists in the Veterans Health Administration.
    Arney J; Helm A; Crook T; Braun UK; Chen GJ; Hayes TG
    Lung Cancer; 2018 Feb; 116():25-29. PubMed ID: 29413047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary care physicians' reported use of pre-screening discussions for prostate cancer screening: a cross-sectional survey.
    Linder SK; Hawley ST; Cooper CP; Scholl LE; Jibaja-Weiss M; Volk RJ
    BMC Fam Pract; 2009 Mar; 10():19. PubMed ID: 19296843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
    Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
    Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness, understanding, attitude and barriers toward prescribing modern cancer immunotherapies in the Arabian Gulf countries.
    Al-Shamsi HO; Tashkandi E; Bukhari N; Al Farsi A; Alnajjar A; Alhuraiji A; Foheidi M; Sagheir A; Bin Thani K; Al Bahrani B; Alrawi S
    Gulf J Oncolog; 2018 May; 1(27):45-51. PubMed ID: 30145551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cross-sectional analysis of routine treatment for prostate cancer patients: CAPRIS - a healthcare research project of the IQUO].
    Schulze M; Stiegler H; Thielecke C; Colling C; Merseburger AS
    Urologe A; 2014 Jun; 53(6):865-70. PubMed ID: 24903838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic disparities in Saskatchewan prostate cancer incidence and its association with physician density: analysis using Bayesian models.
    Andkhoie M; Szafron M
    BMC Cancer; 2021 Aug; 21(1):948. PubMed ID: 34425772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment patterns for older veterans with localized prostate cancer.
    Hoffman RM; Shi Y; Freedland SJ; Keating NL; Walter LC
    Cancer Epidemiol; 2015 Oct; 39(5):769-77. PubMed ID: 26228494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.